fluconazole has been researched along with linezolid in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 12 (60.00) | 24.3611 |
2020's | 4 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Gupta, S; Kamal, A; Narasimha Rao, MP; Shaik, AB; Shetti, RV; Swapna, P | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kulkarni, MR; Lad, NP; Manohar, Y; Mascarenhas, M; Pandit, SS; Pandit, YB; Salkar, K; Sharma, R; Suthar, A | 1 |
Chen, F; Chen, W; Hu, L; Lan, L; Li, B; Li, J; Li, X; Lin, D; Liu, W; Liu, Y; Lu, Y; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Xu, Y; Zheng, X; Zhu, J | 1 |
Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
Abutaleb, NS; Hagras, M; Kotb, A; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
Altobelli, G; Belfiori, B; Malincarne, L; Marroni, M; Papili, R; Stagni, G; Tinca, M | 1 |
Bouza, E; Giannella, M; Guinea, J; Muñoz, P; Palomo, J; Yañez, J | 1 |
Ho, L; Holtom, P; Schiller, F; Schnall, S | 1 |
Dorn, C; Kees, F; Kratzer, A | 1 |
Pararajasingam, A; Uwagwu, J | 1 |
Darling, LA; Evans, AM; Montero, CI; Nattanmai, SM; Stellrecht, KA | 1 |
Aderao, R; Kolekar, K; Nayak, C; Tambe, S | 1 |
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
Chen, SY; Hsu, YC; Huang, YW; Hung, YJ | 1 |
Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
1 review(s) available for fluconazole and linezolid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for fluconazole and linezolid
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Synthesis, biological evaluation of new oxazolidino-sulfonamides as potential antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Dose-Response Relationship, Drug; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Oxazoles; Structure-Activity Relationship; Sulfonamides | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Fungi; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure | 2017 |
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Bacterial; Ether-A-Go-Go Potassium Channels; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship; Vancomycin; Vancomycin Resistance; Xanthophylls | 2017 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
Oxadiazolylthiazoles as novel and selective antifungal agents.
Topics: Antifungal Agents; Aspergillus; Biofilms; Caco-2 Cells; Candida; Cryptococcus; Humans; Microbial Sensitivity Tests; Oxadiazoles; Stereoisomerism; Thiazoles | 2020 |
Nosocomial spondylodiskitis with epidural abscess and CSF fistula cured with quinupristin/dalfopristin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Cerebrospinal Fluid; Combined Modality Therapy; Cross Infection; Curettage; Device Removal; Discitis; Epidural Abscess; Female; Fistula; Fluconazole; Fungi; Humans; Internal Fixators; Laminectomy; Linezolid; Lumbar Vertebrae; Meropenem; Methicillin Resistance; Middle Aged; Osteomyelitis; Oxazolidinones; Parkinson Disease; Prosthesis-Related Infections; Reoperation; Skin Diseases; Spinal Diseases; Spinal Stenosis; Staphylococcal Infections; Thienamycins; Virginiamycin | 2006 |
Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid.
Topics: Acetamides; Actinomycetales Infections; Anti-Bacterial Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Bacterial; Fluconazole; Heart Diseases; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Recurrence; Rhodococcus equi; Transplantation; Treatment Outcome | 2008 |
Metacarpal coccidioidal osteomyelitis.
Topics: Abscess; Acetamides; Anti-Bacterial Agents; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Granuloma; Humans; Linezolid; Magnetic Resonance Imaging; Male; Metacarpal Bones; Middle Aged; Osteomyelitis; Oxazolidinones; Radiography; Treatment Outcome | 2011 |
Unbound fraction of fluconazole and linezolid in human plasma as determined by ultrafiltration: Impact of membrane type.
Topics: Anti-Infective Agents; Cellulose; Chromatography, High Pressure Liquid; Fluconazole; Humans; Linezolid; Polymers; Protein Binding; Sulfones; Ultrafiltration | 2016 |
Topics: Aged; Anti-Bacterial Agents; Colony Count, Microbial; Drainage; Female; Fluconazole; Humans; Immunocompromised Host; Lactobacillus; Lethargy; Linezolid; Liver Abscess; Metronidazole; Microbial Sensitivity Tests; Pleural Effusion; Probiotics; Sepsis; Treatment Outcome; Venous Thrombosis | 2017 |
A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fluconazole; Humans; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2017 |
Chronic vulvovaginitis caused by Candida dubliniensis in an immunologically competent adult female.
Topics: Adult; Antifungal Agents; Candida; Female; Fluconazole; Humans; Linezolid; Treatment Outcome; Vulvovaginitis | 2019 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |
Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients.
Topics: Adult; Anemia; Anti-Bacterial Agents; Fluconazole; Humans; Linezolid; Renal Replacement Therapy; Retrospective Studies; Thrombocytopenia | 2022 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |